介绍

本页面提供了有关 Eric Drape 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示Eric Drape已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Executive VP Global Operations 145,915
如何解读这些图表

以下图表显示了在Eric Drape进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 Eric Drape 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2024-03-07 2024-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 55,226 145,915 60.90
2024-03-07 2024-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 22,576 90,689 33.14
2024-03-05 2024-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 33,512 77,928 75.45
2024-03-05 2024-03-03 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 24,900 44,416 127.59
2024-03-01 2024-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,815 9,701 -50.29 13.12 -128,734 127,238
2024-03-01 2024-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,515 19,516 1,951,500.00
2024-02-21 2024-02-16 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -173,261 1 -100.00 13.05 -2,261,905 13
2023-03-08 2023-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -4,699 173,262 -2.64 9.43 -44,302 1,633,497
2023-03-08 2023-03-06 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,566 177,961 -0.87 9.93 -15,552 1,767,313
2023-03-07 2023-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 22,576 179,527 14.38
2023-03-07 2023-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 33,512 156,951 27.15
2023-03-07 2023-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 11,940 123,439 10.71
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -23,888 111,499 -17.64 9.89 -236,171 1,102,346
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 47,598 135,387 54.22
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,797 87,789 -10.04 9.89 -96,859 867,935
2023-03-02 2023-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,514 97,586 24.99
2022-03-08 2022-03-07 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -11,334 78,072 -12.68 7.37 -83,494 575,133
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -22,576 67,728 -25.00
2022-03-08 2022-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 22,576 89,406 33.78
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 134,048 134,048
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -11,940 11,940 -50.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -32,518 0 -100.00
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,301 66,830 -8.62 7.48 -47,147 500,055
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 11,940 73,131 19.51
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -17,157 61,191 -21.90 7.48 -128,377 457,862
2022-03-08 2022-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 32,518 78,348 70.95
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -19,514 39,029 -33.33
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,797 45,830 -17.61 8.14 -79,769 373,157
2022-03-02 2022-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,514 55,627 54.04
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -6,568 0 -100.00
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,583 36,113 -9.03 9.06 -32,464 327,202
2022-02-10 2022-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 6,568 39,696 19.83
2022-02-10 2022-02-08 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 32,518 32,518
2021-05-25 2021-05-21 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -40,000 33,128 -54.70 11.01 -440,320 364,673
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -37,884 0 -100.00
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -19,804 73,128 -21.31 10.22 -202,413 747,427
2021-05-13 2021-05-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 37,884 92,932 68.82
2021-03-08 2021-03-05 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 90,304 90,304
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -11,940 23,880 -33.33
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,183 55,048 -10.10 10.58 -65,443 582,650
2021-03-08 2021-03-04 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 11,940 61,231 24.22
2021-03-02 2021-03-01 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -9,795 49,291 -16.58 10.85 -106,285 534,852
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -19,514 58,543 -25.00
2021-03-02 2021-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 19,514 59,086 49.31
2021-02-17 2021-02-16 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -2,079 39,572 -4.99 11.13 -23,135 440,361
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,926 0 -100.00
2021-02-17 2021-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,926 41,651 10.41
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 37,884 37,884
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -6,567 6,568 -50.00
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -14,527 37,725 -27.80 12.72 -184,797 479,896
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,452 52,252 -6.20 12.72 -43,913 664,692
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
A - Award 27,643 55,704 98.51
2021-02-11 2021-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 6,567 28,061 30.55
2020-03-03 2020-02-28 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 78,057 78,057
2020-02-20 2020-02-19 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale -8,000 21,494 -27.12 12.51 -100,080 268,890
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -3,926 3,926 -50.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -13,090 0 -100.00
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -1,878 29,494 -5.99 12.14 -22,791 357,930
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -6,262 31,372 -16.64 12.14 -75,994 380,721
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 3,926 37,634 11.65
2020-02-18 2020-02-14 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 13,090 33,708 63.49
2020-02-13 2020-02-11 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
A - Award 13,090 13,090
2020-02-11 2020-02-10 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
S - Sale X -3,144 20,618 -13.23 12.24 -38,488 252,399
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units
M - Exercise -6,567 13,135 -33.33
2020-02-11 2020-02-09 4 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
M - Exercise 6,567 23,762 38.19
2019-10-15 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
34,390
2019-10-15 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
34,390
2019-10-15 3 TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Ordinary Shares
34,390
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)